Hoth Therapeutics, Inc. announced on April 2 the closing of its registered direct offering, raising approximately $2 million through the sale of 2,857,144 shares of common stock at $0.70 per share and concurrent private placement of unregistered warrants to purchase up to an equal number of shares at an exercise price of $0.85 per share.
The announcement is significant for investors and stakeholders as it outlines Hoth’s plans to use the net proceeds from this financing round for general corporate purposes, including working capital.
According to the company, H.C. Wainwright & Co. acted as the exclusive placement agent for this transaction. The unregistered warrants issued in a concurrent private placement will become exercisable six months after issuance and expire five and one-half years later. The securities were offered under a shelf registration statement filed with the Securities and Exchange Commission (SEC) in November 2015 that became effective in December 2025.
Hoth Therapeutics described itself as “a clinical-stage biopharmaceutical company dedicated to developing innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life.” The company said it collaborates with scientists, clinicians, and key opinion leaders to advance therapeutics from early research stages into clinical testing.
The press release also included cautionary statements regarding forward-looking information about business strategies, regulatory submissions, market acceptance, financial results, potential product launches or acquisitions, intellectual property matters and other factors that could affect future outcomes or performance.
PR Newswire distributed this announcement globally through its network that operates in more than 170 countries and supports distribution in over 40 languages according to the official website. PR Newswire aims for global reach by collaborating with over 500,000 media outlets and influencers worldwide; it offers services such as press release distribution along with AI-enhanced content tools according to its official website.
